NATERA
NTRA Insider Trades:
all
Unusual
Whales
Unusual Whales
Unusual Whales
Powered by unusualwhales.com
Ticker
Trade Date
Filing Date
Name
Title
Code
Security
Amount
Price
Value
Trans.
10b5-1
Director
10% Owner
Mcap/AUM
2025-09-19
2025-09-19
RABINOWITZ MATTHEW
EXECUTIVE CHAIRMAN
S - Sale
Common Stock
-25,527
$180.58
-4.61M
2
$24.59B
2025-09-18
2025-09-19
RABINOWITZ MATTHEW
EXECUTIVE CHAIRMAN
S - Sale
Common Stock
-24,473
$180.08
-4.41M
2
$24.59B
2025-09-15
2025-09-17
MOSHKEVICH SOLOMON
PRESIDENT, CLINICALDIAGNOSTICS
G - Gift
Common Stock
-300
$0.00
1
$24.59B
2025-09-12
2025-09-16
RABINOWITZ MATTHEW
EXECUTIVE CHAIRMAN
S - Sale
Common Stock
-5,000
$170.54
-853K
2
$24.59B
2025-09-02
2025-09-05
CHAPMAN STEVEN LEONARD
CEO AND PRESIDENT
S - Sale
Common Stock
-5,079
$166.53
-846K
3
$24.59B
2025-09-02
2025-09-05
MOSHKEVICH SOLOMON
PRESIDENT, CLINICALDIAGNOSTICS
S - Sale
Common Stock
-3,000
$166.62
-500K
3
$24.59B
2025-08-14
2025-08-15
MOSHKEVICH SOLOMON
PRESIDENT, CLINICALDIAGNOSTICS
S - Sale
Common Stock
-875
$155.46
-136K
2
$24.59B
2025-08-14
2025-08-15
FESKO JOHN
PRESIDENT, CHIEF BUS. OFFICER
S - Sale
Common Stock
-678
$155.46
-105K
2
$24.59B
2025-08-12
2025-08-15
MOSHKEVICH SOLOMON
PRESIDENT, CLINICALDIAGNOSTICS
A - Grant
Common Stock
1,675
1
$24.59B
2025-08-01
2025-08-05
CHAPMAN STEVEN LEONARD
CEO AND PRESIDENT
S - Sale
Common Stock
-5,807
$132.88
-772K
2
$24.59B
2025-08-01
2025-08-05
MOSHKEVICH SOLOMON
PRESIDENT, CLINICALDIAGNOSTICS
S - Sale
Common Stock
-3,000
$132.89
-399K
3
$24.59B
2025-07-29
2025-07-30
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
S - Sale
Common Stock
-3,045
$137.40
-418K
3
$24.59B
2025-07-28
2025-07-30
FESKO JOHN
PRESIDENT, CHIEF BUS. OFFICER
S - Sale
Common Stock
-1,710
$139.81
-239K
1
$24.59B
2025-07-28
2025-07-30
RABINOWITZ MATTHEW
EXECUTIVE CHAIRMAN
S - Sale
Common Stock
-1,718
$139.81
-240K
1
$24.59B
2025-07-28
2025-07-30
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
S - Sale
Common Stock
-1,994
$139.81
-279K
1
$24.59B
2025-07-28
2025-07-30
MOSHKEVICH SOLOMON
PRESIDENT, CLINICALDIAGNOSTICS
S - Sale
Common Stock
-2,206
$139.81
-308K
1
$24.59B
2025-07-28
2025-07-30
FESKO JOHN
PRESIDENT, CHIEF BUS. OFFICER
S - Sale
Common Stock
-1,710
$139.81
-239K
1
$24.59B
2025-07-28
2025-07-30
CHAPMAN STEVEN LEONARD
CEO AND PRESIDENT
S - Sale
Common Stock
-6,092
$139.81
-852K
1
$24.59B
2025-07-28
2025-07-30
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
S - Sale
Common Stock
-2,019
$139.81
-282K
1
$24.59B
2025-07-28
2025-07-30
RABINOWITZ MATTHEW
EXECUTIVE CHAIRMAN
S - Sale
Common Stock
-1,718
$139.81
-240K
1
$24.59B
2025-07-28
2025-07-30
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
S - Sale
Common Stock
-1,994
$139.81
-279K
1
$24.59B
2025-07-28
2025-07-30
MOSHKEVICH SOLOMON
PRESIDENT, CLINICALDIAGNOSTICS
S - Sale
Common Stock
-2,206
$139.81
-308K
1
$24.59B
2025-07-28
2025-07-30
CHAPMAN STEVEN LEONARD
CEO AND PRESIDENT
S - Sale
Common Stock
-6,092
$139.81
-852K
1
$24.59B
2025-07-28
2025-07-30
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
S - Sale
Common Stock
-2,019
$139.81
-282K
1
$24.59B
2025-07-24
2025-07-24
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
S - Sale
Common Stock
-755
$139.50
-105K
2
$24.59B
2025-07-23
2025-07-24
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
S - Sale
Common Stock
-495
$141.28
-69,933.6
1
$24.59B
2025-07-22
2025-07-24
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
M - Exercise
Restricted Stock Unit
-1,250
$0.00
1
$24.59B
2025-07-22
2025-07-24
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
M - Exercise
Common Stock
1,250
1
$24.59B
2025-07-22
2025-07-24
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
S - Sale
Common Stock
-920
$139.58
-128K
1
$24.59B
2025-07-21
2025-07-22
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
S - Sale
Common Stock
-602
$139.29
-83,852.58
1
$24.59B
2025-07-21
2025-07-22
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
S - Sale
Common Stock
-464
$139.29
-64,630.56
1
$24.59B
2025-07-21
2025-07-22
MOSHKEVICH SOLOMON
PRESIDENT, CLINICALDIAGNOSTICS
S - Sale
Common Stock
-291
$139.29
-40,533.39
1
$24.59B
2025-07-21
2025-07-22
FESKO JOHN
PRESIDENT, CHIEF BUS. OFFICER
S - Sale
Common Stock
-339
$139.29
-47,219.31
1
$24.59B
2025-07-21
2025-07-22
CHAPMAN STEVEN LEONARD
CEO AND PRESIDENT
S - Sale
Common Stock
-1,622
$139.29
-226K
1
$24.59B
2025-07-20
2025-07-22
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
M - Exercise
Restricted Stock Unit
-856
$0.00
1
$24.59B
2025-07-20
2025-07-22
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
M - Exercise
Restricted Stock Unit
-1,522
$0.00
1
$24.59B
2025-07-20
2025-07-22
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
M - Exercise
Common Stock
1,522
1
$24.59B
2025-07-20
2025-07-22
CHAPMAN STEVEN LEONARD
CEO AND PRESIDENT
M - Exercise
Restricted Stock Unit
-3,386
$0.00
1
$24.59B
2025-07-20
2025-07-22
CHAPMAN STEVEN LEONARD
CEO AND PRESIDENT
M - Exercise
Common Stock
3,386
1
$24.59B
2025-07-20
2025-07-22
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
M - Exercise
Common Stock
856
1
$24.59B
2025-06-20
2025-07-22
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
S - Sale
Common Stock
-9,908
$170.83
-1.69M
2
$24.59B
2025-06-18
2025-07-22
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
S - Sale
Common Stock
-10,000
$170.18
-1.70M
1
$24.59B
2025-05-27
2025-07-22
MOSHKEVICH SOLOMON
PRESIDENT, CLINICALDIAGNOSTICS
S - Sale
Common Stock
-1,649
$156.85
-259K
1
$24.59B
2025-05-27
2025-07-22
FESKO JOHN
PRESIDENT, CHIEF BUS. OFFICER
S - Sale
Common Stock
-1,438
$156.85
-226K
1
$24.59B
2025-07-01
2025-07-03
MOSHKEVICH SOLOMON
PRESIDENT, CLINICALDIAGNOSTICS
S - Sale
Common Stock
-3,000
$166.77
-500K
4
$24.59B
2025-07-01
2025-07-03
CHAPMAN STEVEN LEONARD
CEO AND PRESIDENT
S - Sale
Common Stock
-2,156
$165.56
-357K
3
$24.59B
2025-07-01
2025-07-03
CHAPMAN STEVEN LEONARD
CEO AND PRESIDENT
S - Sale
Common Stck
-3,187
$167.19
-533K
1
$24.59B
2025-06-13
2025-06-20
RABINOWITZ MATTHEW
EXECUTIVE CHAIRMAN
S - Sale
Common Stock
-5,000
$166.00
-830K
1
$24.59B
2025-05-28
2025-06-20
RABINOWITZ MATTHEW
EXECUTIVE CHAIRMAN
S - Sale
Common Stock
-10,000
$161.00
-1.61M
1
$24.59B
2025-05-20
2025-06-20
RABINOWITZ MATTHEW
EXECUTIVE CHAIRMAN
S - Sale
Common Stock
-10,000
$154.00
-1.54M
1
$24.59B
2025-05-16
2025-06-20
RABINOWITZ MATTHEW
EXECUTIVE CHAIRMAN
S - Sale
Common Stock
-19,000
$153.00
-2.91M
2
$24.59B
2025-05-15
2025-06-20
RABINOWITZ MATTHEW
EXECUTIVE CHAIRMAN
S - Sale
Common Stock
-10,000
$150.00
-1.50M
1
$24.59B
2025-06-18
2025-06-18
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
S - Sale
-19,908
$168.00
-3.34M
1
$24.59B
2025-06-02
2025-06-04
MOSHKEVICH SOLOMON
PRESIDENT, CLINICALDIAGNOSTICS
S - Sale
Common Stock
-3,000
$157.00
-471K
4
$24.59B
2025-06-02
2025-06-04
CHAPMAN STEVEN LEONARD
CEO AND PRESIDENT
S - Sale
Common Stock
-6,111
$157.00
-959K
3
$24.59B
2025-05-01
2025-05-02
CHAPMAN STEVEN LEONARD
CEO AND PRESIDENT
S - Sale
Common Stock
-6,980
$150.00
-1.05M
4
$24.59B
2025-05-01
2025-05-02
MOSHKEVICH SOLOMON
PRESIDENT, CLINICALDIAGNOSTICS
S - Sale
Common Stock
-3,000
$150.00
-450K
4
$24.59B
2025-04-29
2025-04-30
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
S - Sale
Common Stock
-3,045
$154.00
-469K
4
$24.59B
2025-04-28
2025-04-30
FESKO JOHN
PRESIDENT, CHIEF BUS. OFFICER
S - Sale
Common Stock
-1,709
$152.00
-260K
1
$24.59B
2025-04-28
2025-04-30
MOSHKEVICH SOLOMON
PRESIDENT, CLINICALDIAGNOSTICS
G - Gift
Common Stock
-75
$0.00
1
$24.59B
2025-04-28
2025-04-30
CHAPMAN STEVEN LEONARD
CEO AND PRESIDENT
S - Sale
Common Stock
-6,203
$152.00
-943K
1
$24.59B
2025-04-28
2025-04-30
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
S - Sale
Common Stock
-2,018
$152.00
-307K
1
$24.59B
2025-04-28
2025-04-30
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
S - Sale
Common Stock
-1,993
$152.00
-303K
1
$24.59B
2025-04-28
2025-04-30
RABINOWITZ MATTHEW
EXECUTIVE CHAIRMAN
S - Sale
Common Stock
-1,718
$152.00
-261K
1
$24.59B
2025-04-28
2025-04-30
MOSHKEVICH SOLOMON
PRESIDENT, CLINICALDIAGNOSTICS
S - Sale
Common Stock
-2,206
$152.00
-335K
1
$24.59B
2025-04-24
2025-04-24
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
S - Sale
Common Stock
-755
$152.00
-115K
2
$24.59B
2025-04-23
2025-04-24
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
S - Sale
Common Stock
-495
$151.00
-74,745
1
$24.59B
2025-04-22
2025-04-24
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
M - Exercise
Common Stock
1,250
1
$24.59B
2025-04-22
2025-04-24
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
S - Sale
Common Stock
-911
$145.00
-132K
2
$24.59B
2025-04-22
2025-04-24
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
M - Exercise
Restricted Stock Unit
-1,250
$0.00
1
$24.59B
2025-04-21
2025-04-22
CHAPMAN STEVEN LEONARD
CEO AND PRESIDENT
S - Sale
Common Stock
-1,664
$146.00
-243K
2
$24.59B
2025-04-21
2025-04-22
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
S - Sale
Common Stock
-610
$146.00
-89,060
2
$24.59B
2025-04-21
2025-04-22
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
S - Sale
Common Stock
-470
$146.00
-68,620
2
$24.59B
2025-04-21
2025-04-22
MOSHKEVICH SOLOMON
PRESIDENT, CLINICALDIAGNOSTICS
S - Sale
Common Stock
-296
$146.00
-43,216
2
$24.59B
2025-04-21
2025-04-22
FESKO JOHN
PRESIDENT, CHIEF BUS. OFFICER
S - Sale
Common Stock
-343
$146.00
-50,078
2
$24.59B
2025-04-20
2025-04-22
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
M - Exercise
Restricted Stock Unit
-1,521
$0.00
1
$24.59B
2025-04-20
2025-04-22
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
M - Exercise
Common Stock
856
1
$24.59B
2025-04-20
2025-04-22
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
M - Exercise
Restricted Stock Unit
-856
$0.00
1
$24.59B
2025-04-20
2025-04-22
CHAPMAN STEVEN LEONARD
CEO AND PRESIDENT
M - Exercise
Common Stock
3,386
1
$24.59B
2025-04-20
2025-04-22
CHAPMAN STEVEN LEONARD
CEO AND PRESIDENT
M - Exercise
Restricted Stock Unit
-3,386
$0.00
1
$24.59B
2025-04-20
2025-04-22
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
M - Exercise
Common Stock
1,521
1
$24.59B
2025-04-01
2025-04-03
MOSHKEVICH SOLOMON
PRESIDENT, CLINICALDIAGNOSTICS
S - Sale
Common Stock
-3,000
$140.00
-420K
3
$24.59B
2025-04-01
2025-04-01
CHAPMAN STEVEN LEONARD
CEO AND PRESIDENT
S - Sale
Common Stock
-15,898
$140.00
-2.23M
4
$24.59B
2025-04-01
2025-04-01
CHAPMAN STEVEN LEONARD
CEO AND PRESIDENT
S - Sale
Common Stock
-15,898
$140.00
-2.23M
4
$24.59B
2025-04-01
2025-04-01
CHAPMAN STEVEN LEONARD
CEO AND PRESIDENT
S - Sale
Common Stock
-15,898
$140.00
-2.23M
4
$24.59B
2025-04-01
2025-04-01
CHAPMAN STEVEN LEONARD
CEO AND PRESIDENT
S - Sale
Common Stock
-15,898
$140.00
-2.23M
4
$24.59B
2025-03-31
2025-04-01
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
S - Sale
Common Stock
-1,404
$138.00
-194K
2
$24.59B
2025-03-31
2025-04-01
CHAPMAN STEVEN LEONARD
CEO AND PRESIDENT
S - Sale
Common Stock
-9,563
$138.00
-1.32M
2
$24.59B
2025-03-31
2025-04-01
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
S - Sale
Common Stock
-2,562
$138.00
-354K
2
$24.59B
2025-03-28
2025-04-01
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
M - Exercise
Common Stock
6,250
1
$24.59B
2025-03-28
2025-04-01
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
M - Exercise
Restricted Stock Unit
-6,250
$0.00
1
$24.59B
2025-03-28
2025-04-01
CHAPMAN STEVEN LEONARD
CEO AND PRESIDENT
M - Exercise
Restricted Stock Unit
-18,750
$0.00
1
$24.59B
2025-03-28
2025-04-01
CHAPMAN STEVEN LEONARD
CEO AND PRESIDENT
M - Exercise
Common Stock
18,750
1
$24.59B
2025-03-28
2025-04-01
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
M - Exercise
Common Stock
2,500
1
$24.59B
2025-03-28
2025-04-01
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
M - Exercise
Restricted Stock Unit
-2,500
$0.00
1
$24.59B
2025-03-17
2025-03-19
MOSHKEVICH SOLOMON
PRESIDENT, CLINICALDIAGNOSTICS
S - Sale
Common Stock
-1,026
$146.00
-150K
2
$24.59B
2025-03-17
2025-03-19
FESKO JOHN
PRESIDENT, CHIEF BUS. OFFICER
S - Sale
Common Stock
-795
$146.00
-116K
2
$24.59B
2025-03-17
2025-03-19
CHAPMAN STEVEN LEONARD
CEO AND PRESIDENT
S - Sale
Common Stock
-6,702
$146.00
-978K
1
$24.59B
2025-03-17
2025-03-19
RABINOWITZ MATTHEW
EXECUTIVE CHAIRMAN
S - Sale
Common Stock
-1,127
$146.00
-165K
2
$24.59B
2025-03-17
2025-03-19
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
S - Sale
Common Stock
-928
$146.00
-135K
2
$24.59B
2025-03-17
2025-03-19
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
S - Sale
Common Stock
-792
$146.00
-116K
2
$24.59B
2025-03-14
2025-03-14
RABINOWITZ MATTHEW
EXECUTIVE CHAIRMAN
S - Sale
Common Stock
-50,000
$148.00
-7.40M
5
$24.59B
2025-03-12
2025-03-14
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
A - Grant
Common Stock
2,032
1
$24.59B
2025-03-12
2025-03-14
MOSHKEVICH SOLOMON
PRESIDENT, CLINICALDIAGNOSTICS
A - Grant
Common Stock
2,040
1
$24.59B
2025-03-12
2025-03-14
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
A - Grant
Common Stock
1,740
1
$24.59B
2025-03-05
2025-03-07
CHAPMAN STEVEN LEONARD
CEO AND PRESIDENT
S - Sale
Common Stock
-87,272
$143.00
-12M
5
$24.59B
2025-03-05
2025-03-07
MOSHKEVICH SOLOMON
PRESIDENT, CLINICALDIAGNOSTICS
S - Sale
Common Stock
-6,000
$143.00
-858K
4
$24.59B
2025-02-06
2025-02-07
MOSHKEVICH SOLOMON
PRESIDENT, CLINICALDIAGNOSTICS
S - Sale
Common Stock
-1,632
$178.00
-290K
1
$24.59B
2025-02-06
2025-02-07
FESKO JOHN
PRESIDENT, CHIEF BUS. OFFICER
S - Sale
Common Stock
-663
$178.00
-118K
1
$24.59B
2025-02-05
2025-02-07
MOSHKEVICH SOLOMON
PRESIDENT, CLINICALDIAGNOSTICS
A - Grant
Common Stock
3,197
2
$24.59B
2025-02-03
2025-02-04
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
S - Sale
Common Stock
-43,502
$177.00
-7.70M
4
$24.59B
2025-01-31
2025-02-04
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
S - Sale
Common Stock
-400
$173.00
-69,200
1
$24.59B
2025-01-31
2025-02-04
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
S - Sale
Common Stock
-400
$173.00
-69,200
1
$24.59B
2025-01-31
2025-02-04
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
S - Sale
Common Stock
-400
$173.00
-69,200
1
$24.59B
2025-01-31
2025-02-04
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
A - Grant
Common Stock
10,353
1
$24.59B
2025-01-31
2025-02-04
MOSHKEVICH SOLOMON
PRESIDENT, CLINICALDIAGNOSTICS
A - Grant
Common Stock
12,720
1
$24.59B
2025-01-31
2025-02-04
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
A - Grant
Common Stock
12,720
1
$24.59B
2025-01-31
2025-02-04
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
A - Grant
Common Stock
10,353
1
$24.59B
2025-01-31
2025-02-04
MOSHKEVICH SOLOMON
PRESIDENT, CLINICALDIAGNOSTICS
A - Grant
Common Stock
12,720
1
$24.59B
2025-01-31
2025-02-04
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
A - Grant
Common Stock
12,720
1
$24.59B
2025-01-31
2025-02-04
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
A - Grant
Common Stock
10,353
1
$24.59B
2025-01-31
2025-02-04
MOSHKEVICH SOLOMON
PRESIDENT, CLINICALDIAGNOSTICS
A - Grant
Common Stock
12,720
1
$24.59B
2025-01-31
2025-02-04
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
A - Grant
Common Stock
12,720
1
$24.59B
2025-02-03
2025-02-03
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
S - Sale
-43,902
$177.00
-7.77M
1
$24.59B
2025-01-31
2025-01-31
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
S - Sale
Common Stock
-1,886
$177.00
-334K
1
$24.59B
2025-01-29
2025-01-31
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
S - Sale
Common Stock
-4,335
$166.00
-720K
4
$24.59B
2025-01-29
2025-01-31
CHAPMAN STEVEN LEONARD
CEO AND PRESIDENT
S - Sale
Common Stock
-13,685
$166.00
-2.27M
4
$24.59B
2025-01-29
2025-01-31
FESKO JOHN
PRESIDENT, CHIEF BUS. OFFICER
S - Sale
Common Stock
-4,030
$166.00
-669K
3
$24.59B
2025-01-29
2025-01-31
MOSHKEVICH SOLOMON
PRESIDENT, CLINICALDIAGNOSTICS
S - Sale
Common Stock
-5,201
$166.00
-863K
3
$24.59B
2025-01-29
2025-01-31
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
S - Sale
Common Stock
-4,773
$166.00
-792K
3
$24.59B
2025-01-29
2025-01-31
RABINOWITZ MATTHEW
EXECUTIVE CHAIRMAN
S - Sale
Common Stock
-6,003
$166.00
-996K
2
$24.59B
2025-01-29
2025-01-31
FESKO JOHN
PRESIDENT, CHIEF BUS. OFFICER
S - Sale
Common Stock
-4,030
$166.00
-669K
3
$24.59B
2025-01-29
2025-01-31
CHAPMAN STEVEN LEONARD
CEO AND PRESIDENT
S - Sale
Common Stock
-13,685
$166.00
-2.27M
4
$24.59B
2025-01-29
2025-01-31
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
S - Sale
Common Stock
-4,335
$166.00
-720K
4
$24.59B
2025-01-29
2025-01-31
MOSHKEVICH SOLOMON
PRESIDENT, CLINICALDIAGNOSTICS
S - Sale
Common Stock
-5,201
$166.00
-863K
3
$24.59B
2025-01-29
2025-01-31
RABINOWITZ MATTHEW
EXECUTIVE CHAIRMAN
S - Sale
Common Stock
-6,003
$166.00
-996K
2
$24.59B
2025-01-29
2025-01-31
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
S - Sale
Common Stock
-4,773
$166.00
-792K
3
$24.59B
2025-01-29
2025-01-31
MOSHKEVICH SOLOMON
PRESIDENT, CLINICALDIAGNOSTICS
S - Sale
Common Stock
-5,201
$166.00
-863K
3
$24.59B
2025-01-29
2025-01-31
FESKO JOHN
PRESIDENT, CHIEF BUS. OFFICER
S - Sale
Common Stock
-4,030
$166.00
-669K
3
$24.59B
2025-01-29
2025-01-31
CHAPMAN STEVEN LEONARD
CEO AND PRESIDENT
S - Sale
Common Stock
-13,685
$166.00
-2.27M
4
$24.59B
2025-01-29
2025-01-31
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
S - Sale
Common Stock
-4,335
$166.00
-720K
4
$24.59B
2025-01-29
2025-01-31
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
S - Sale
Common Stock
-4,773
$166.00
-792K
3
$24.59B
2025-01-29
2025-01-31
RABINOWITZ MATTHEW
EXECUTIVE CHAIRMAN
S - Sale
Common Stock
-6,003
$166.00
-996K
2
$24.59B
2025-01-27
2025-01-29
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
S - Sale
Common Stock
-1,442
$162.00
-234K
1
$24.59B
2025-01-27
2025-01-29
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
S - Sale
Common Stock
-1,442
$162.00
-234K
1
$24.59B
2025-01-24
2025-01-24
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
S - Sale
Common Stock
-946
$172.00
-163K
2
$24.59B
2025-01-24
2025-01-24
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
S - Sale
Common Stock
-946
$172.00
-163K
2
$24.59B
2025-01-23
2025-01-24
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
S - Sale
Common Stock
-495
$171.00
-84,645
1
$24.59B
2025-01-22
2025-01-24
MOSHKEVICH SOLOMON
PRESIDENT, CLINICALDIAGNOSTICS
S - Sale
Common Stock
-24,861
$165.00
-4.10M
2
$24.59B
2025-01-22
2025-01-24
MOSHKEVICH SOLOMON
PRESIDENT, CLINICALDIAGNOSTICS
S - Sale
Common Stock
-24,861
$165.00
-4.10M
2
$24.59B
2025-01-22
2025-01-24
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
M - Exercise
Common Stock
1,250
1
$24.59B
2025-01-22
2025-01-24
FESKO JOHN
PRESIDENT, CHIEF BUS. OFFICER
S - Sale
Common Stock
-21,228
$165.00
-3.50M
2
$24.59B
2025-01-22
2025-01-24
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
M - Exercise
Common Stock
1,250
1
$24.59B
2025-01-22
2025-01-24
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
M - Exercise
Restricted Stock Unit
-1,250
$0.00
1
$24.59B
2025-01-22
2025-01-24
FESKO JOHN
PRESIDENT, CHIEF BUS. OFFICER
S - Sale
Common Stock
-21,228
$165.00
-3.50M
2
$24.59B
2025-01-22
2025-01-24
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
M - Exercise
Restricted Stock Unit
-1,250
$0.00
1
$24.59B
2025-01-22
2025-01-22
CHAPMAN STEVEN LEONARD
CEO AND PRESIDENT
S - Sale
Common Stock
-78,553
$165.00
-13M
2
$24.59B
2025-01-22
2025-01-22
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
S - Sale
Common Stock
-25,931
$165.00
-4.28M
2
$24.59B
2025-01-22
2025-01-22
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
S - Sale
Common Stock
-22,039
$165.00
-3.64M
2
$24.59B
2025-01-21
2025-01-22
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
M - Exercise
Common Stock
644
1
$24.59B
2025-01-21
2025-01-22
CHAPMAN STEVEN LEONARD
CEO AND PRESIDENT
M - Exercise
Common Stock
1,775
1
$24.59B
2025-01-21
2025-01-22
CHAPMAN STEVEN LEONARD
CEO AND PRESIDENT
M - Exercise
Restricted Stock Unit
-1,775
$0.00
1
$24.59B
2025-01-21
2025-01-22
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
M - Exercise
Restricted Stock Unit
-644
$0.00
1
$24.59B
2025-01-21
2025-01-22
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
M - Exercise
Restricted Stock Unit
-1,145
$0.00
1
$24.59B
2025-01-21
2025-01-22
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
M - Exercise
Common Stock
1,145
1
$24.59B
2025-01-20
2025-01-22
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
M - Exercise
Restricted Stock Unit
-856
$0.00
1
$24.59B
2025-01-20
2025-01-22
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
M - Exercise
Common Stock
856
1
$24.59B
2025-01-20
2025-01-22
CHAPMAN STEVEN LEONARD
CEO AND PRESIDENT
M - Exercise
Common Stock
3,386
1
$24.59B
2025-01-20
2025-01-22
CHAPMAN STEVEN LEONARD
CEO AND PRESIDENT
M - Exercise
Restricted Stock Unit
-3,386
$0.00
1
$24.59B
2025-01-20
2025-01-22
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
M - Exercise
Common Stock
1,522
1
$24.59B
2025-01-20
2025-01-22
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
M - Exercise
Restricted Stock Unit
-1,522
$0.00
1
$24.59B
2025-01-16
2025-01-21
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
A - Grant
Common Stock
39,730
1
$24.59B
2025-01-16
2025-01-21
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
A - Grant
Common Stock
24,832
1
$24.59B
2025-01-16
2025-01-21
MOSHKEVICH SOLOMON
PRESIDENT, CLINICALDIAGNOSTICS
A - Grant
Common Stock
48,548
3
$24.59B
2025-01-16
2025-01-21
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
A - Grant
Common Stock
39,730
1
$24.59B
2025-01-16
2025-01-21
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
A - Grant
Common Stock
24,832
1
$24.59B
2025-01-16
2025-01-21
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
A - Grant
Common Stock
39,730
1
$24.59B
2025-01-16
2025-01-21
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
M - Exercise
Common Stock
13,696
1
$24.59B
2025-01-16
2025-01-21
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
M - Exercise
Restricted Stock Unit
-13,696
$0.00
1
$24.59B
2025-01-16
2025-01-21
CHAPMAN STEVEN LEONARD
CEO AND PRESIDENT
M - Exercise
Common Stock
54,175
1
$24.59B
2025-01-16
2025-01-21
CHAPMAN STEVEN LEONARD
CEO AND PRESIDENT
M - Exercise
Restricted Stock Unit
-54,175
$0.00
1
$24.59B
2025-01-16
2025-01-21
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
M - Exercise
Common Stock
24,348
1
$24.59B
2025-01-16
2025-01-21
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
M - Exercise
Common Stock
13,696
1
$24.59B
2025-01-16
2025-01-21
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
M - Exercise
Restricted Stock Unit
-13,696
$0.00
1
$24.59B
2025-01-16
2025-01-21
CHAPMAN STEVEN LEONARD
CEO AND PRESIDENT
M - Exercise
Common Stock
54,175
1
$24.59B
2025-01-16
2025-01-21
CHAPMAN STEVEN LEONARD
CEO AND PRESIDENT
M - Exercise
Restricted Stock Unit
-54,175
$0.00
1
$24.59B
2025-01-16
2025-01-21
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
M - Exercise
Common Stock
24,348
1
$24.59B
2025-01-16
2025-01-21
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
M - Exercise
Restricted Stock Unit
-24,348
$0.00
1
$24.59B
2025-01-16
2025-01-21
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
M - Exercise
Common Stock
13,696
1
$24.59B
2025-01-16
2025-01-21
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
M - Exercise
Restricted Stock Unit
-13,696
$0.00
1
$24.59B
2025-01-16
2025-01-21
CHAPMAN STEVEN LEONARD
CEO AND PRESIDENT
M - Exercise
Common Stock
54,175
1
$24.59B
2025-01-16
2025-01-21
CHAPMAN STEVEN LEONARD
CEO AND PRESIDENT
M - Exercise
Restricted Stock Unit
-54,175
$0.00
1
$24.59B
2025-01-16
2025-01-21
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
M - Exercise
Common Stock
24,348
1
$24.59B
2025-01-16
2025-01-21
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
M - Exercise
Restricted Stock Unit
-24,348
$0.00
1
$24.59B
2025-01-16
2025-01-21
MOSHKEVICH SOLOMON
PRESIDENT, CLINICALDIAGNOSTICS
A - Grant
Common Stock
48,548
3
$24.59B
2025-01-16
2025-01-21
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
M - Exercise
Restricted Stock Unit
-24,348
$0.00
1
$24.59B
2025-01-16
2025-01-21
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
A - Grant
Common Stock
24,832
1
$24.59B
2025-01-16
2025-01-21
MOSHKEVICH SOLOMON
PRESIDENT, CLINICALDIAGNOSTICS
A - Grant
Common Stock
48,548
3
$24.59B
2025-01-08
2025-01-10
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
S - Sale
Common Stock
-6,223
$175.00
-1.09M
1
$24.59B
2024-12-23
2024-12-26
MOSHKEVICH SOLOMON
PRESIDENT, CLINICALDIAGNOSTICS
S - Sale
Common Stock
-2,428
$160.00
-388K
3
$24.59B
2024-12-23
2024-12-26
FESKO JOHN
PRESIDENT, CHIEF BUS. OFFICER
S - Sale
Common Stock
-669
$160.00
-107K
2
$24.59B
2024-12-20
2024-12-26
MOSHKEVICH SOLOMON
PRESIDENT, CLINICALDIAGNOSTICS
A - Grant
Common Stock
4,719
2
$24.59B
2024-12-23
2024-12-23
MOSHKEVICH SOLOMON
PRESIDENT, CLINICALDIAGNOSTICS
G - Gift
Common Stock
-81
$0.00
1
$24.59B
2024-12-19
2024-12-23
MOSHKEVICH SOLOMON
PRESIDENT, CLINICALDIAGNOSTICS
G - Gift
Common Stock
-125
$0.00
1
$24.59B
2024-12-13
2024-12-13
RABINOWITZ MATTHEW
EXECUTIVE CHAIRMAN
S - Sale
Common Stock
-160K
$166.00
-27M
5
$24.59B
2024-12-09
2024-12-11
MOSHKEVICH SOLOMON
PRESIDENT, CLINICALDIAGNOSTICS
S - Sale
Common Stock
-4,858
$167.00
-811K
1
$24.59B
2024-12-09
2024-12-11
MOSHKEVICH SOLOMON
PRESIDENT, CLINICALDIAGNOSTICS
M - Exercise
Stock Option (right to buy)
-9,075
$0.00
2
$24.59B
2024-12-09
2024-12-11
MOSHKEVICH SOLOMON
PRESIDENT, CLINICALDIAGNOSTICS
A - Grant
Common Stock
9,075
$9.00
81,675
2
$24.59B
2024-12-05
2024-12-09
RABINOWITZ MATTHEW
EXECUTIVE CHAIRMAN
M - Exercise
Stock Option (right to buy)
-68,496
$0.00
1
$24.59B
2024-12-05
2024-12-09
RABINOWITZ MATTHEW
EXECUTIVE CHAIRMAN
M - Exercise
Common Stock
68,496
$5.00
342K
1
$24.59B
2024-11-26
2024-11-27
RABINOWITZ MATTHEW
EXECUTIVE CHAIRMAN
S - Sale
Common Stock
-2,000
$164.00
-328K
3
$24.59B
2024-11-25
2024-11-27
RABINOWITZ MATTHEW
EXECUTIVE CHAIRMAN
S - Sale
Common Stock
-2,000
$169.00
-338K
3
$24.59B
2024-11-15
2024-11-15
CHAPMAN STEVEN LEONARD
CEO AND PRESIDENT
S - Sale
Common Stok
-100
$146.00
-14,600
1
$24.59B
2024-11-15
2024-11-15
CHAPMAN STEVEN LEONARD
CEO AND PRESIDENT
S - Sale
Common Stock
-4,628
$146.00
-676K
5
$24.59B
2024-11-12
2024-11-13
RABINOWITZ MATTHEW
EXECUTIVE CHAIRMAN
M - Exercise
Stock Option (right to buy)
-10,000
$0.00
1
$24.59B
2024-11-12
2024-11-13
RABINOWITZ MATTHEW
EXECUTIVE CHAIRMAN
M - Exercise
Common Stock
10,000
$5.00
50,000
1
$24.59B
2024-11-11
2024-11-13
RABINOWITZ MATTHEW
EXECUTIVE CHAIRMAN
M - Exercise
Stock Option (right to buy)
-130K
$0.00
1
$24.59B
2024-11-11
2024-11-13
RABINOWITZ MATTHEW
EXECUTIVE CHAIRMAN
M - Exercise
Common Stock
130K
$5.00
650K
1
$24.59B
2024-10-31
2024-11-01
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
S - Sale
Common Stock
-1,866
$126.00
-235K
1
$24.59B
2024-10-29
2024-10-30
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
S - Sale
Common Stock
-754
$120.00
-90,480
1
$24.59B
2024-10-28
2024-10-30
FESKO JOHN
PRESIDENT, CHIEF BUS. OFFICER
S - Sale
Common Stock
-929
$118.00
-110K
1
$24.59B
2024-10-28
2024-10-30
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
S - Sale
Common Stock
-1,238
$118.00
-146K
1
$24.59B
2024-10-28
2024-10-30
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
S - Sale
Common Stock
-1,057
$118.00
-125K
1
$24.59B
2024-10-28
2024-10-30
MOSHKEVICH SOLOMON
PRESIDENT, CLINICALDIAGNOSTICS
S - Sale
Common Stock
-1,196
$118.00
-141K
1
$24.59B
2024-10-28
2024-10-30
CHAPMAN STEVEN LEONARD
CEO AND PRESIDENT
S - Sale
Common Stock
-3,960
$118.00
-467K
1
$24.59B
2024-10-25
2024-10-25
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
S - Sale
Common Stock
-691
$119.00
-82,229
1
$24.59B
2024-10-24
2024-10-25
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
S - Sale
Common Stock
-914
$119.00
-109K
1
$24.59B
2024-10-24
2024-10-24
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
S - Sale
-1,605
$119.00
-191K
1
$24.59B
2024-10-23
2024-10-23
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
S - Sale
Common Stock
-496
$119.00
-59,024
1
$24.59B
2024-10-22
2024-10-23
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
M - Exercise
Restricted Stock Unit
-1,250
$0.00
1
$24.59B
2024-10-22
2024-10-23
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
M - Exercise
Common Stock
1,250
1
$24.59B
2024-10-22
2024-10-23
MOSHKEVICH SOLOMON
PRESIDENT, CLINICALDIAGNOSTICS
S - Sale
Common Stock
-256
$120.00
-30,720
1
$24.59B
2024-10-22
2024-10-23
FESKO JOHN
PRESIDENT, CHIEF BUS. OFFICER
S - Sale
Common Stock
-199
$120.00
-23,880
1
$24.59B
2024-10-21
2024-10-23
FESKO JOHN
PRESIDENT, CHIEF BUS. OFFICER
S - Sale
Common Stock
-342
$121.00
-41,382
1
$24.59B
2024-10-21
2024-10-23
MOSHKEVICH SOLOMON
PRESIDENT, CLINICALDIAGNOSTICS
S - Sale
Common Stock
-294
$121.00
-35,574
1
$24.59B
2024-10-22
2024-10-22
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
S - Sale
Common Stock
-349
$120.00
-41,880
1
$24.59B
2024-10-22
2024-10-22
CHAPMAN STEVEN LEONARD
CEO AND PRESIDENT
S - Sale
Common Stock
-893
$120.00
-107K
1
$24.59B
2024-10-22
2024-10-22
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
S - Sale
Common Stock
-454
$120.00
-54,480
1
$24.59B
2024-10-21
2024-10-22
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
M - Exercise
Common Stock
644
1
$24.59B
2024-10-21
2024-10-22
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
M - Exercise
Restricted Stock Unit
-1,145
$0.00
1
$24.59B
2024-10-21
2024-10-22
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
M - Exercise
Common Stock
1,145
1
$24.59B
2024-10-21
2024-10-22
CHAPMAN STEVEN LEONARD
CEO AND PRESIDENT
M - Exercise
Restricted Stock Unit
-1,775
$0.00
1
$24.59B
2024-10-21
2024-10-22
CHAPMAN STEVEN LEONARD
CEO AND PRESIDENT
M - Exercise
Common Stock
1,775
1
$24.59B
2024-10-21
2024-10-22
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
M - Exercise
Restricted Stock Unit
-644
$0.00
1
$24.59B
2024-10-21
2024-10-22
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
S - Sale
Common Stock
-467
$121.00
-56,507
1
$24.59B
2024-10-21
2024-10-22
CHAPMAN STEVEN LEONARD
CEO AND PRESIDENT
S - Sale
Common Stock
-1,709
$121.00
-207K
1
$24.59B
2024-10-21
2024-10-22
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
S - Sale
Common Stock
-608
$121.00
-73,568
1
$24.59B
2024-10-20
2024-10-22
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
M - Exercise
Restricted Stock Unit
-856
$0.00
1
$24.59B
2024-10-20
2024-10-22
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
M - Exercise
Common Stock
1,522
1
$24.59B
2024-10-20
2024-10-22
CHAPMAN STEVEN LEONARD
CEO AND PRESIDENT
M - Exercise
Restricted Stock Unit
-3,386
$0.00
1
$24.59B
2024-10-20
2024-10-22
CHAPMAN STEVEN LEONARD
CEO AND PRESIDENT
M - Exercise
Common Stock
3,386
1
$24.59B
2024-10-20
2024-10-22
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
M - Exercise
Common Stock
856
1
$24.59B
2024-10-20
2024-10-22
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
M - Exercise
Restricted Stock Unit
-1,522
$0.00
1
$24.59B
2024-10-15
2024-10-17
CHAPMAN STEVEN LEONARD
CEO AND PRESIDENT
S - Sale
Common Stock
-4,523
$130.00
-588K
1
$24.59B
2024-09-16
2024-09-18
CHAPMAN STEVEN LEONARD
CEO AND PRESIDENT
S - Sale
Common Stock
-5,024
$128.00
-643K
5
$24.59B
2024-08-15
2024-08-16
CHAPMAN STEVEN LEONARD
CEO AND PRESIDENT
S - Sale
Common Stock
-5,583
$119.00
-664K
2
$24.59B
2024-08-13
2024-08-14
FESKO JOHN
PRESIDENT, CHIEF BUS. OFFICER
S - Sale
Common Stock
-3,956
$117.00
-463K
1
$24.59B
2024-08-08
2024-08-09
RABINOWITZ MATTHEW
EXECUTIVE CHAIRMAN
M - Exercise
Common Stock
190K
$5.00
950K
1
$24.59B
2024-08-08
2024-08-09
RABINOWITZ MATTHEW
EXECUTIVE CHAIRMAN
M - Exercise
Stock Option (right to buy)
-190K
$0.00
1
$24.59B
2024-07-31
2024-07-31
FESKO JOHN
PRESIDENT, CHIEF BUS. OFFICER
M - Exercise
Stock Option (right to buy)
-100
$0.00
1
$24.59B
2024-07-31
2024-07-31
FESKO JOHN
PRESIDENT, CHIEF BUS. OFFICER
M - Exercise
Common Stock
100
$5.00
500
1
$24.59B
2024-07-31
2024-07-31
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
S - Sale
Common Stock
-1,866
$100.00
-187K
1
$24.59B
2024-07-29
2024-07-31
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
S - Sale
Common Stock
-1,057
$103.00
-109K
1
$24.59B
2024-07-29
2024-07-31
MOSHKEVICH SOLOMON
PRESIDENT, CLINICALDIAGNOSTICS
S - Sale
Common Stock
-1,196
$103.00
-123K
1
$24.59B
2024-07-29
2024-07-31
FESKO JOHN
PRESIDENT, CHIEF BUS. OFFICER
S - Sale
Common Stock
-929
$103.00
-95,687
1
$24.59B
2024-07-29
2024-07-31
CHAPMAN STEVEN LEONARD
CEO AND PRESIDENT
S - Sale
Common Stock
-4,084
$103.00
-421K
1
$24.59B
2024-07-29
2024-07-31
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
S - Sale
Common Stock
-1,238
$103.00
-128K
1
$24.59B
2024-07-26
2024-07-26
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
S - Sale
Common Stock
-751
$102.00
-76,602
1
$24.59B
2024-07-25
2024-07-26
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
S - Sale
Common Stock
-690
$105.00
-72,450
1
$24.59B
2024-07-24
2024-07-26
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
S - Sale
Common Stock
-918
$106.00
-97,308
1
$24.59B
2024-07-24
2024-07-24
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
S - Sale
-1,608
$107.00
-172K
1
$24.59B
2024-07-23
2024-07-23
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
S - Sale
Common Stock
-499
$107.00
-53,393
1
$24.59B
2024-07-22
2024-07-23
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
S - Sale
Common Stock
-1,059
$105.00
-111K
1
$24.59B
2024-07-22
2024-07-23
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
M - Exercise
Common Stock
1,250
1
$24.59B
2024-07-22
2024-07-23
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
M - Exercise
Restricted Stock Unit
-1,250
$0.00
1
$24.59B
2024-07-22
2024-07-23
CHAPMAN STEVEN LEONARD
CEO AND PRESIDENT
S - Sale
Common Stock
-2,638
$105.00
-277K
1
$24.59B
2024-07-22
2024-07-23
FESKO JOHN
PRESIDENT, CHIEF BUS. OFFICER
S - Sale
Common Stock
-549
$105.00
-57,645
1
$24.59B
2024-07-22
2024-07-23
MOSHKEVICH SOLOMON
PRESIDENT, CLINICALDIAGNOSTICS
S - Sale
Common Stock
-549
$105.00
-57,645
1
$24.59B
2024-07-22
2024-07-23
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
S - Sale
Common Stock
-815
$105.00
-85,575
1
$24.59B
2024-07-21
2024-07-23
CHAPMAN STEVEN LEONARD
CEO AND PRESIDENT
M - Exercise
Common Stock
1,774
1
$24.59B
2024-07-21
2024-07-23
CHAPMAN STEVEN LEONARD
CEO AND PRESIDENT
M - Exercise
Restricted Stock Unit
-1,774
$0.00
1
$24.59B
2024-07-21
2024-07-23
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
M - Exercise
Common Stock
1,145
1
$24.59B
2024-07-21
2024-07-23
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
M - Exercise
Restricted Stock Unit
-1,145
$0.00
1
$24.59B
2024-07-21
2024-07-23
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
M - Exercise
Common Stock
644
1
$24.59B
2024-07-21
2024-07-23
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
M - Exercise
Restricted Stock Unit
-644
$0.00
1
$24.59B
2024-07-20
2024-07-23
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
M - Exercise
Common Stock
856
1
$24.59B
2024-07-20
2024-07-23
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
M - Exercise
Restricted Stock Unit
-856
$0.00
1
$24.59B
2024-07-20
2024-07-23
CHAPMAN STEVEN LEONARD
CEO AND PRESIDENT
M - Exercise
Common Stock
3,386
1
$24.59B
2024-07-20
2024-07-23
CHAPMAN STEVEN LEONARD
CEO AND PRESIDENT
M - Exercise
Restricted Stock Unit
-3,386
$0.00
1
$24.59B
2024-07-20
2024-07-23
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
M - Exercise
Common Stock
1,522
1
$24.59B
2024-07-20
2024-07-23
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
M - Exercise
Restricted Stock Unit
-1,522
$0.00
1
$24.59B
2024-07-15
2024-07-17
CHAPMAN STEVEN LEONARD
CEO AND PRESIDENT
S - Sale
Common Stock
-5,496
$112.00
-616K
2
$24.59B
2024-07-01
2024-07-02
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
S - Sale
Common Stock
-4,983
$108.00
-538K
1
$24.59B
2024-07-01
2024-07-02
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
S - Sale
Common Stock
-2,723
$108.00
-294K
1
$24.59B
2024-07-01
2024-07-02
CHAPMAN STEVEN LEONARD
CEO AND PRESIDENT
S - Sale
Common Stock
-37,500
$108.00
-4.05M
3
$24.59B
2024-06-28
2024-07-02
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
M - Exercise
Common Stock
12,500
1
$24.59B
2024-06-28
2024-07-02
BROPHY MICHAEL BURKES
CHIEF FINANCIAL OFFICER
M - Exercise
Restricted Stock Unit
-12,500
$0.00
1
$24.59B
2024-06-28
2024-07-02
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
M - Exercise
Restricted Stock Unit
-5,000
$0.00
1
$24.59B
2024-06-28
2024-07-02
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
M - Exercise
Common Stock
5,000
1
$24.59B
2024-06-28
2024-07-02
CHAPMAN STEVEN LEONARD
CEO AND PRESIDENT
M - Exercise
Restricted Stock Unit
-37,500
$0.00
1
$24.59B
2024-06-28
2024-07-02
CHAPMAN STEVEN LEONARD
CEO AND PRESIDENT
M - Exercise
Common Stock
37,500
1
$24.59B
2024-06-17
2024-06-18
CHAPMAN STEVEN LEONARD
CEO AND PRESIDENT
S - Sale
Common Stock
-6,105
$112.00
-684K
3
$24.59B
2024-05-28
2024-05-30
MOSHKEVICH SOLOMON
PRESIDENT, CLINICALDIAGNOSTICS
S - Sale
Common Stock
-1,647
$110.00
-181K
1
$24.59B